Suzhou Ribo Life Science Company
Tracked across 2 events · 14 articles · First seen May 06, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Suzhou Ribo Life Science Company achieved a key milestone in its research collaboration with Boehringer Ingelheim for MASH therapies, highlighting its siRNA discovery and liver targeted delivery capabilities and solidifying its position as a strategic partner.
May 06, 2026 · 7 articles
Tech
Impact: Suzhou Ribo Life Science Company, along with its subsidiary KC Pharmaceuticals, has achieved a significant milestone in its siRNA partnership with KC Pharmaceuticals, Inc. for MASH therapies, which is expected to positively impact its stock and reputation.
Jul 02, 2026 · 7 articles
100
Suzhou Ribo Life Science Company achieved milestone KC PharmaceuticalsRibo, Madrigal MASH Drug Milestone
100
KC Pharmaceuticals achieved milestone Suzhou Ribo Life Science CompanyRibo, Madrigal MASH Drug Milestone
ERGEN INTELLIGENCE
Track Suzhou Ribo Life Science Company live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard